{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T14:18:55Z","timestamp":1793110735422,"version":"4.5.0"},"reference-count":82,"publisher":"Informa UK Limited","issue":"9","license":[{"start":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T00:00:00Z","timestamp":1783296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1080\/policies-text-data-mining"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Anti-infective Therapy"],"published-print":{"date-parts":[[2026,9,2]]},"DOI":"10.1080\/14787210.2026.2695445","type":"journal-article","created":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T05:36:08Z","timestamp":1783316168000},"page":"845-853","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":1,"title":["The changing picture of community acquired urinary tract infections in the US: a daunting prospect"],"prefix":"10.1080","volume":"24","author":[{"given":"Teena","family":"Chopra","sequence":"first","affiliation":[{"name":"Vibra Hospital","place":["Detroit, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glenn","family":"Tillotson","sequence":"additional","affiliation":[{"name":"GST Micro LLC","place":["North, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Donald","sequence":"additional","affiliation":[{"name":"GST Micro LLC","place":["Halifax, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,7,6]]},"reference":[{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.5492"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1047-2797(00)00072-7"},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(02)01054-9"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-135-1-200107030-00004"},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001209.pub2"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.f3140"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.idc.2013.09.003"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp1104429"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2022.888205"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofw281"},{"issue":"169","key":"e_1_3_4_13_1","first-page":"1","article-title":"Ambulatory medical care utilization estimates for 2007","volume":"13","author":"Schappert SM","year":"2011","unstructured":"Schappert SM, Rechtsteiner EA. Ambulatory medical care utilization estimates for 2007. Vital Health Stat. 2011;13(169):1\u201338.","journal-title":"Vital Health Stat"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/acem.12287"},{"issue":"26","key":"e_1_3_4_15_1","first-page":"1","article-title":"National hospital ambulatory medical care survey: 2007 emergency department summary","volume":"6","author":"Niska R","year":"2010","unstructured":"Niska R, Bhuiya F, Xu J. National hospital ambulatory medical care survey: 2007 emergency department summary. Natl Health Stat Report. 2010;6(26):1\u201331.","journal-title":"Natl Health Stat Report"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaf459"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciq257"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.7326\/M20-7355"},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.1097\/JU.0000000000000296"},{"key":"e_1_3_4_20_1","doi-asserted-by":"publisher","DOI":"10.1128\/microbiolspec.UTI-0002-2012"},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofz446"},{"key":"e_1_3_4_22_1","doi-asserted-by":"publisher","DOI":"10.1007\/s15010-007-6180-2"},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00125-13"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annemergmed.2020.08.022"},{"key":"e_1_3_4_25_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkx146"},{"key":"e_1_3_4_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgar.2015.05.005"},{"key":"e_1_3_4_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(08)70041-0"},{"key":"e_1_3_4_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.meegid.2018.04.005"},{"key":"e_1_3_4_29_1","unstructured":"World Health Organization. Global antimicrobial resistance and use surveillance system (GLASS) report 2022. Geneva Switzerland: World Health Organization; 2022 [cited 2026 Jan 13]. Available from: https:\/\/iris.who.int\/server\/api\/core\/bitstreams\/e5cc3da6-f46e-4355-a352-8d16820e0dd1\/content"},{"key":"e_1_3_4_30_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1914433"},{"key":"e_1_3_4_31_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0220265"},{"key":"e_1_3_4_32_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp1702758"},{"key":"e_1_3_4_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annemergmed.2018.05.006"},{"key":"e_1_3_4_34_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaf460"},{"key":"e_1_3_4_35_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciae403"},{"key":"e_1_3_4_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2026.107787"},{"key":"e_1_3_4_37_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkad147"},{"key":"e_1_3_4_38_1","doi-asserted-by":"publisher","DOI":"10.1017\/ice.2021.496"},{"key":"e_1_3_4_39_1","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofab466.1618"},{"key":"e_1_3_4_40_1","doi-asserted-by":"publisher","DOI":"10.3201\/eid2209.160148"},{"key":"e_1_3_4_41_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciab005"},{"key":"e_1_3_4_42_1","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofab591"},{"key":"e_1_3_4_43_1","doi-asserted-by":"publisher","DOI":"10.3201\/eid1402.070350"},{"key":"e_1_3_4_44_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01338-09"},{"key":"e_1_3_4_45_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jis933"},{"key":"e_1_3_4_46_1","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00116-14"},{"key":"e_1_3_4_47_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1322678111"},{"key":"e_1_3_4_48_1","doi-asserted-by":"publisher","DOI":"10.1128\/mSphere.00314-16"},{"key":"e_1_3_4_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2020.02.019"},{"key":"e_1_3_4_50_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciw193"},{"key":"e_1_3_4_51_1","doi-asserted-by":"publisher","DOI":"10.1086\/669865"},{"key":"e_1_3_4_52_1","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2016.21.42.30376"},{"key":"e_1_3_4_53_1","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofz004"},{"key":"e_1_3_4_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajic.2022.06.019"},{"key":"e_1_3_4_55_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkad234"},{"key":"e_1_3_4_56_1","doi-asserted-by":"publisher","DOI":"10.3201\/eid2011.141388"},{"key":"e_1_3_4_57_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00732-17"},{"key":"e_1_3_4_58_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2022-069166"},{"key":"e_1_3_4_59_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02240-19"},{"key":"e_1_3_4_60_1","doi-asserted-by":"publisher","DOI":"10.1002\/emp2.12694"},{"key":"e_1_3_4_61_1","unstructured":"Office of the Assistant Secretary for Planning and Evaluation USDoHHS. Trends in the utilization of emergency department services 2009\u20132018. 2021 [cited 2022 Aug 23]. Available from:https:\/\/aspe.hhs.gov\/pdf-report\/utilization-emergency-department-services"},{"key":"e_1_3_4_62_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2015.08.012"},{"key":"e_1_3_4_63_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2018.06.018"},{"key":"e_1_3_4_64_1","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofx163.1435"},{"key":"e_1_3_4_65_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkm318"},{"key":"e_1_3_4_66_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dks065"},{"key":"e_1_3_4_67_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2019-030266"},{"key":"e_1_3_4_68_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13756-022-01121-y"},{"key":"e_1_3_4_69_1","unstructured":"U.S. Food and Drug Administration. FDA approves new treatment for uncomplicated urinary tract infections April 24. 2024 [cited 2026 Jan 13]. Available from: https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-new-treatment-uncomplicated-urinary-tract-infections"},{"key":"e_1_3_4_70_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaf280"},{"key":"e_1_3_4_71_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkac396"},{"key":"e_1_3_4_72_1","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofae296"},{"key":"e_1_3_4_73_1","doi-asserted-by":"publisher","DOI":"10.1128\/aac.01824-24"},{"key":"e_1_3_4_74_1","doi-asserted-by":"publisher","DOI":"10.1128\/cmr.00042-24"},{"key":"e_1_3_4_75_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2105462"},{"key":"e_1_3_4_76_1","unstructured":"Spero Therapeutics. Spero announces NDA resubmission of tebipenem HBr by GSK to the FDA for the treatment of complicated urinary tract infections including pyelonephritis: globe newswire press release. 2025 [cited 2026 Jan 13]. Available from: https:\/\/s3.amazonaws.com\/b2icontent.irpass.cc\/2748\/rl160626.pdf"},{"key":"e_1_3_4_77_1","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.01898-24"},{"key":"e_1_3_4_78_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciac704"},{"key":"e_1_3_4_79_1","doi-asserted-by":"publisher","DOI":"10.1056\/EVIDoa2400414"},{"key":"e_1_3_4_80_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2024.10.025"},{"key":"e_1_3_4_81_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(23)02196-7"},{"key":"e_1_3_4_82_1","doi-asserted-by":"publisher","DOI":"10.1128\/aac.01525-22"},{"key":"e_1_3_4_83_1","doi-asserted-by":"publisher","DOI":"10.1080\/17460913.2025.2460387"},{"key":"e_1_3_4_84_1","unstructured":"GSK. Blujepa (gepotidacin) approved by US FDA for treatment of uncomplicated urinary tract infections (uUtis) in female adults and paediatric patients 12 years of age and older. News release; 2025 [cited 2026 Jan 30]. Available from: https:\/\/www.gsk.com\/en-gb\/media\/press-releases\/blujepa-gepotidacin-approved-by-us-fda-for-treatment-of-uncomplicated-urinary-tract-infections\/"}],"container-title":["Expert Review of Anti-infective Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14787210.2026.2695445","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/full-xml\/10.1080\/14787210.2026.2695445","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14787210.2026.2695445","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T10:25:52Z","timestamp":1788258352000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14787210.2026.2695445"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,6]]},"references-count":82,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9,2]]}},"alternative-id":["10.1080\/14787210.2026.2695445"],"URL":"https:\/\/doi.org\/10.1080\/14787210.2026.2695445","relation":{},"ISSN":["1478-7210","1744-8336"],"issn-type":[{"value":"1478-7210","type":"print"},{"value":"1744-8336","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,6]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierz20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierz20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2026-03-24","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-23","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-06","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}